SBL
CVS icon

Sargent Bickham Lagudis’s CVS Health CVS Stock Holding History

Sargent Bickham Lagudis’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$881K Buy
9,449
+29
+0.3% +$2.8K 0.07% 139
2022
Q3 		$899K Sell
9,420
-115
-1% -$11.4K 0.08% 132
2022
Q2 		$883K Buy
9,535
+398
+4% +$38.8K 0.08% 142
2022
Q1 		$925K Sell
9,137
-78
-0.8% -$8.19K 0.07% 144
2021
Q4 		$951K Buy
9,215
+120
+1% +$11.1K 0.07% 136
2021
Q3 		$772K Buy
9,095
+957
+12% +$80.2K 0.06% 139
2021
Q2 		$679K Buy
8,138
+292
+4% +$23.9K 0.06% 145
2021
Q1 		$590K Buy
7,846
+407
+5% +$29.6K 0.05% 146
2020
Q4 		$508K Buy
7,439
+3,229
+77% +$210K 0.05% 159
2020
Q3 		$246K Buy
4,210
+469
+13% +$29.2K 0.02% 191
2020
Q2 		$243K Buy
3,741
+1,096
+41% +$69K 0.03% 183
2020
Q1 		$157K Buy
2,645
+114
+5% +$7.61K 0.02% 213
2019
Q4 		$188K Buy
2,531
+181
+8% +$12.7K 0.02% 205
2019
Q3 		$148K Buy
2,350
+91
+4% +$5.39K 0.02% 216
2019
Q2 		$123K Buy
2,259
+295
+15% +$15.9K 0.01% 256
2019
Q1 		$106K Buy
1,964
+268
+16% +$16.5K 0.01% 279
2018
Q4 		$111K Buy
1,696
+43
+3% +$3.21K 0.01% 257
2018
Q3 		$130K Buy
1,653
+354
+27% +$25.3K 0.02% 246
2018
Q2 		$84K Sell
1,299
-154
-11% -$10.1K 0.01% 291
2018
Q1 		$90K Buy
1,453
+141
+11% +$10.1K 0.01% 279
2017
Q4 		$95K Buy
1,312
+1,082
+470% +$78.7K 0.01% 283
2017
Q3 		$19K Hold
230
– – ﹤0.01% 504
2017
Q2 		$18K Buy
230
+29
+14% +$2.29K ﹤0.01% 489
2017
Q1 		$16K Sell
201
-610
-75% -$48.7K ﹤0.01% 518
2016
Q4 		$64K Sell
811
-135
-14% -$10.9K 0.01% 302
2016
Q3 		$3.31K Sell
946
-37,420
-98% -$3.53M 0.5% 60
2016
Q2 		$3.67M Sell
38,366
-2,481
-6% -$247K 0.57% 50
2016
Q1 		$4.24M Buy
+40,847
New +$3.97M 0.68% 35

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sargent Bickham Lagudis's CVS Position: Q4 2022 in Review

Sargent Bickham Lagudis increased its CVS Health (CVS) stake by 0.31% in Q4 2022, buying an estimated $2.8K and bringing the position to 9,449 shares worth $881K. The position accounts for 0.07% of the portfolio, ranked #139.

Sargent Bickham Lagudis first reported a position in CVS in Q1 2016 and has held it in 28 quarters since. The position peaked at $4.24M in Q1 2016. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Sargent Bickham Lagudis held 9,449 shares of CVS Health worth $881K as of Q4 2022.
  • Sargent Bickham Lagudis bought 29 CVS Health shares in Q4 2022, an estimated $2.8K.
  • CVS Health made up 0.07% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #139 holding.
  • Sargent Bickham Lagudis first reported a position in CVS Health in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's CVS Health position peaked at $4.24M in Q1 2016.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.